Fresenius Medical Care held its Annual General Meeting (AGM) on August 27, 2020 as a virtual event, without the physical presence of shareholders.
Our profile 2019 is now available and can be downloaded here.
Fresenius Medical Care, the world’s leading provider of dialysis products and services, has agreed to issue bonds with an aggregate principal amount of USD 1 billion.
Solid revenue growth continued; Significant net income growth; Exceptionally positive free cash flow development; Financial targets for FY2020 confirmed inclusive of anticipated COVID-19 effects
Read more about our main financing instruments, senior notes and the credit ratings.